143 related articles for article (PubMed ID: 1458584)
1. Reference values for immunoglobulin kappa and lambda light chains and the kappa/lambda ratio in children's serum.
Saitta M; Iavarone A; Cappello N; Bergami MR; Fiorucci GC; Aguzzi F
Clin Chem; 1992 Dec; 38(12):2454-7. PubMed ID: 1458584
[TBL] [Abstract][Full Text] [Related]
2. Pediatric and perinatal reference intervals for immunoglobulin light chains kappa and lambda.
Herkner KR; Salzer H; Böck A; Mühl A; Tsaka T; Steger H; Pollak A; Schatten C; Popp W; Huber-Spitzy V
Clin Chem; 1992 Apr; 38(4):548-50. PubMed ID: 1568320
[TBL] [Abstract][Full Text] [Related]
3. Determination of kappa and lambda light chains in serum immunoglobulins G, A and M.
Haraldsson A; Kock-Jansen MJ; Jaminon M; van Eck-Arts PB; de Boo T; Weemaes CM; Bakkeren JA
Ann Clin Biochem; 1991 Sep; 28 ( Pt 5)():461-6. PubMed ID: 1958048
[TBL] [Abstract][Full Text] [Related]
4. Light chain ratios and concentrations of serum immunoglobulins in children with epilepsy.
Haraldsson A; van Engelen BG; Renier WO; Bakkeren JA; Weemaes CM
Epilepsy Res; 1992 Dec; 13(3):255-60. PubMed ID: 1493788
[TBL] [Abstract][Full Text] [Related]
5. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
6. Critical evaluation of the serum kappa/lambda light-chain ratio in the detection of M proteins.
Laine ST; Soppi ET; Mörsky PJ
Clin Chim Acta; 1992 Apr; 207(1-2):143-9. PubMed ID: 1591862
[No Abstract] [Full Text] [Related]
7. Kappa/lambda ratio as parameter for evaluation of therapy-resistant epilepsy of childhood.
Lischka A; Graf M; Hauser E; Herkner KR
Eur Neurol; 1994; 34 Suppl 1():74-8. PubMed ID: 8001615
[TBL] [Abstract][Full Text] [Related]
8. Nephelometry of the kappa/lambda light-chain ratio in serum of normal and diseased children.
Renckens AL; Jansen MJ; van Munster PJ; Weemaes CM; Bakkeren JA
Clin Chem; 1986 Dec; 32(12):2147-9. PubMed ID: 3096608
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic reference range of κ/λ free light chain ratio to screen for Bence Jones proteinuria is not significantly influenced by GFR.
Schmidt-Hieltjes Y; Elshof C; Roovers L; Ruinemans-Koerts J
Eur J Haematol; 2016 May; 96(5):527-31. PubMed ID: 26172558
[TBL] [Abstract][Full Text] [Related]
10. Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels.
Ye Y; Li SL; Xie M; Jiang P; Liu KG; Li YJ
Kaohsiung J Med Sci; 2013 Oct; 29(10):547-53. PubMed ID: 24099109
[TBL] [Abstract][Full Text] [Related]
11. Use of kappa and lambda chain quantitation for the detection of immunoglobulin abnormalities in serum.
Normansell DE
Diagn Clin Immunol; 1987; 5(2):100-3. PubMed ID: 3113758
[TBL] [Abstract][Full Text] [Related]
12. Verification of serum reference intervals for free light chains in a local South African population.
Zemlin AE; Rensburg MA; Ipp H; Germishuys JJ; Erasmus RT
J Clin Pathol; 2013 Nov; 66(11):992-5. PubMed ID: 23801498
[TBL] [Abstract][Full Text] [Related]
13. Novel extended reference range for serum kappa/lambda free light chain ratio in diagnosing monoclonal gammopathies in renal insufficient patients.
Diamantidis MD; Ioannidou-Papagiannaki E; Ntaios G
Clin Biochem; 2009 Jul; 42(10-11):1202-3. PubMed ID: 19375413
[No Abstract] [Full Text] [Related]
14. Assessment of serum free light chain levels in healthy adults immediately after marathon running.
Campbell JP; Eijsvogels TM; Wang Y; Hopman MT; Jacobs JF
Clin Chem Lab Med; 2016 Mar; 54(3):459-65. PubMed ID: 26351935
[TBL] [Abstract][Full Text] [Related]
15. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies: High False-Positive Rate.
Singh G
Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
17. Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients.
Bourguignon C; Chenine L; Bargnoux AS; Leray-Moragues H; Canaud B; Cristol JP; Morena M
J Nephrol; 2016 Apr; 29(2):251-257. PubMed ID: 26022721
[TBL] [Abstract][Full Text] [Related]
18. Higher serum levels of free ĸ plus λ immunoglobulin light chains ameliorate survival of hemodialysis patients.
Thilo F; Caspari C; Scholze A; Tepel M
Kidney Blood Press Res; 2011; 34(5):344-9. PubMed ID: 21646814
[TBL] [Abstract][Full Text] [Related]
19. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser.
Maisin D; Lepoutre T; Gruson D; Wallemacq P
Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296
[TBL] [Abstract][Full Text] [Related]
20. [Immunonephelometric analysis of immunoglobulin light chains: agreement between the theoretical and experimental model. Assessment of the reference values of the kappa/lambda ratio and the heavy to light chain ratio].
Chapuis-Cellier C; Cloppet H; Chazaud A; Coquelin H
J Pharm Belg; 1996; 51(1):23-27. PubMed ID: 8882446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
